Literature DB >> 16263692

Mono-(3-carboxypropyl) phthalate, a metabolite of di-n-octyl phthalate.

Antonia M Calafat1, Manori J Silva, John A Reidy, L Earl Gray, Ella Samandar, James L Preau, Arnetra R Herbert, Larry L Needham.   

Abstract

Di-n-octyl phthalate (DnOP) is found as a component of mixed C6-C10 linear-chain phthalates used as plasticizers in various polyvinyl chloride applications, including flooring and carpet tiles. Following exposure and absorption, DnOP is metabolized to its hydrolytic monoester, mono-n-octyl phthalate (MnOP), and other oxidative products. The urinary levels of one of these oxidative metabolites, mono-(3-carboxypropyl) phthalate (MCPP), were about 560-fold higher than MnOP in Sprague-Dawley rats dosed with DnOP by gavage. Furthermore, MCPP was also found in the urine of rats dosed with di-isooctyl phthalate (DiOP), di-isononyl phthalate (DiNP), di-isodecyl phthalate (DiDP), di-(2-ethylhexyl) phthalate, and di-n-butyl phthalate (DBP), although at concentrations considerably lower than in rats given similar concentrations of DnOP. The comparatively much higher urinary concentrations of MCPP than of the hydrolytic monoesters of the high-molecular-weight phthalates DiOP, DiNP, and DiDP in the exposed rats suggest that these monoesters may be poor biomarkers of exposure to their precursor phthalates and may explain the relatively low frequency of detection of these monoester metabolites in human populations. MCPP and MnOP were also measured in 267 human urine samples. The frequent detection and higher urinary concentrations of MCPP than MnOP suggest that exposure to DnOP might be higher than previously thought based on the measurements of MnOP alone. However, because MCPP is also a minor metabolite of DBP and other phthalates in rats, and the metabolism of phthalates in rodents and humans may differ, additional data on the absorption, distribution, metabolism, and elimination of MCPP are needed to completely understand the extent of human exposure to DnOP from the urinary concentrations of MCPP.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16263692     DOI: 10.1080/15287390500227381

Source DB:  PubMed          Journal:  J Toxicol Environ Health A        ISSN: 0098-4108


  20 in total

1.  Urinary phthalate metabolite concentrations among men with inflammatory bowel disease on mesalamine therapy.

Authors:  Elizabeth J Hait; Antonia M Calafat; Russ Hauser
Journal:  Endocr Disruptors (Austin)       Date:  2014-10-20

Review 2.  Exposure assessment issues in epidemiology studies of phthalates.

Authors:  Lauren E Johns; Glinda S Cooper; Audrey Galizia; John D Meeker
Journal:  Environ Int       Date:  2015-08-24       Impact factor: 9.621

3.  Association of Exposure to Di-2-Ethylhexylphthalate Replacements With Increased Insulin Resistance in Adolescents From NHANES 2009-2012.

Authors:  Teresa M Attina; Leonardo Trasande
Journal:  J Clin Endocrinol Metab       Date:  2015-05-20       Impact factor: 5.958

4.  Exposure Marker Discovery of Phthalates Using Mass Spectrometry.

Authors:  Jen-Yi Hsu; Chia-Lung Shih; Pao-Chi Liao
Journal:  Mass Spectrom (Tokyo)       Date:  2017-03-24

5.  Exposure to phthalates and breast cancer risk in northern Mexico.

Authors:  Lizbeth López-Carrillo; Raúl U Hernández-Ramírez; Antonia M Calafat; Luisa Torres-Sánchez; Marcia Galván-Portillo; Larry L Needham; Rubén Ruiz-Ramos; Mariano E Cebrián
Journal:  Environ Health Perspect       Date:  2010-04       Impact factor: 9.031

6.  Prenatal Phthalate Exposures and Body Mass Index Among 4- to 7-Year-old Children: A Pooled Analysis.

Authors:  Jessie P Buckley; Stephanie M Engel; Joseph M Braun; Robin M Whyatt; Julie L Daniels; Michelle A Mendez; David B Richardson; Yingying Xu; Antonia M Calafat; Mary S Wolff; Bruce P Lanphear; Amy H Herring; Andrew G Rundle
Journal:  Epidemiology       Date:  2016-05       Impact factor: 4.822

7.  Medications as a potential source of exposure to phthalates among women of childbearing age.

Authors:  Sonia Hernández-Díaz; Yung-Cheng Su; Allen A Mitchell; Katherine E Kelley; Antonia M Calafat; Russ Hauser
Journal:  Reprod Toxicol       Date:  2013-01-18       Impact factor: 3.143

8.  Concentrations of phthalates and DINCH metabolites in pooled urine from Queensland, Australia.

Authors:  M J Gomez Ramos; A L Heffernan; L M L Toms; A M Calafat; X Ye; P Hobson; S Broomhall; J F Mueller
Journal:  Environ Int       Date:  2016-01-04       Impact factor: 9.621

Review 9.  Presence of phthalates in gastrointestinal medications: is there a hidden danger?

Authors:  Zane R Gallinger; Geoffrey C Nguyen
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

10.  Medications as a potential source of exposure to phthalates in the U.S. population.

Authors:  Sonia Hernández-Díaz; Allen A Mitchell; Katherine E Kelley; Antonia M Calafat; Russ Hauser
Journal:  Environ Health Perspect       Date:  2008-10-07       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.